The scarcity of foreign exchange is having rippled negative effects on the ability of GSK Consumer Nigeria Plc to sustain the supply of drugs, the management has said.
In a statement issued and signed on behalf of the company by Mr Omongiade Ehighebolo, Director of Communication and Government Affairs, he said the scarcity was a serious cause for concern.
In the statement which reads in part, he acknowledged that “In common with many companies operating in Nigeria, foreign exchange availability continues to impact our operations” adding that “the challenge in accessing currency is affecting our ability to maintain consistent supply of medicines and vaccines in the market.”
Read Also: The Benefits of Using a Forex Trading App
Noting that “Sustainable patient access to our medicines and vaccines is a priority and we are doing all we can to limit the period of time the market will be out-of-stock on our products,” the management reiterated that it recognised that the current availability challenge is causing concern and also regretted the disruption to patients and healthcare providers.
“We are actively engaging with all our stakeholders to find a solution to enable sustainable supply of GSK medicines and vaccines to patients in Nigeria,” he stressed, while urging all patients to seek advice from their healthcare providers and ensure their medicines come from a trusted source.